The NINDS has launched the Collaborative Program to Accelerate Therapeutics Development for Spinal Muscular Atrophy (SMA). Science Applications International Corporation (SAIC) is supporting the NINDS in the management of this program. SAIC will release a series of Requests for Proposals (RFPs) to solicit research consistent with the program’s strategic plan. Through SAIC, NINDS is now accepting proposals for the first RFP under this program, to develop an inducible mouse model for SMA. Successful offerors will be supported through subcontracts under the SAIC prime contract N01-NS-3-2356.